Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000466986 | SCV000549473 | likely benign | Birt-Hogg-Dube syndrome | 2025-02-02 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV001017707 | SCV001178830 | benign | Hereditary cancer-predisposing syndrome | 2023-09-02 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV003477974 | SCV004219733 | benign | not provided | 2022-05-03 | criteria provided, single submitter | clinical testing | |
Myriad Genetics, |
RCV004787731 | SCV005404865 | likely benign | Birt-Hogg-Dube syndrome 1 | 2024-08-27 | criteria provided, single submitter | clinical testing | This variant is considered likely benign. This variant has been observed at a population frequency that is significantly greater than expected given the associated disease prevalence and penetrance. |